Antiva Biosciences Competitors and Similar CompaniesClear all
Antiva Biosciences's competitors and similar companies include Albireo Pharma, United Biomedical, Genexine and Se-cure Pharmaceuticals.
 Antiva Biosciences Antiva Biosciences is a biopharmaceutical company which develops therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection. |  Albireo Pharma Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases. |  United Biomedical United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. |  Genexine Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics. |  Se-cure Pharmaceuticals Se-cure Pharmaceuticals is a research-driven pharmaceutical company that develops a platform for the development and scaling of therapies of botanical origin. | |
Founding Date | Founding Date 2012 | Founding Date 2003 | Founding Date 1985 | Founding Date 1999 | Founding Date 1997 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations South San Francisco, US HQ Redwood City, US | Locations Boston, US HQ Göteborg, SE | Locations Seongnam-si, KR HQ New York, US | Locations HQ | |
Employees | Employees N/A | Employees 5541% increase | Employees 45 | Employees 86 | Employees 195% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $40.6m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) ₩4.6b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1.4m (FY, 2021) | Cost of goods N/A | Cost of goods (₩503.7m) (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $39.2m (FY, 2021) | Gross profit N/A | Gross profit ₩7.8b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($34m) (FY, 2021) | Net income N/A | Net income (₩27.2b) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 56.4m | Total funding raised $ 40m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Albireo Pharma
HQ
Boston, US
Employees
55↑ 41% increase
Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.
View companyUnited Biomedical
HQ
Hauppauge, US
Employees
45
United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.
View companyGenexine
HQ
Seongnam-si, KR
Employees
86
Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics.
View companySe-cure Pharmaceuticals
HQ
Employees
19↓ 5% decrease
Se-cure Pharmaceuticals is a research-driven pharmaceutical company that develops a platform for the development and scaling of therapies of botanical origin.
View company